Literature DB >> 970988

Factors relating to circulating immune complexes in rheumatoid arthirits.

P J Roberts-Thomson, B L Hazleman, I G Barnett, I C MacLennan, A G Mowat.   

Abstract

Evidence has been presented suggesting that circulating immune complexes occur in over half of the sera of patients with rheumatoid arthritis. These IgG-containing complexes were small, eluting between IgG and IgM on gel filtration on Sepharose 6B and were not seen in the sera of healthy control subjects. These complexes were detected in the sera of both seronegative and seropositive patients and their quantity did not correlate with IgM rheumatoid factor titre. The quantity of complexed IgG was estimated from a ratio derived from the IgG profile obtained by gel filtration of the serum. This quantity correlated significantly with the degree of inhibition by the rheumatoid sera of cytolysis in vitro of IgG sensitized target cells by K cells from human peripheral blood. A significant inverse correlation was observed between the quantity of serum complexes and the chemotactic index of the circulating polymorphonuclear leucocytes obtained from the same rheumatoid patient. It is suggested that ingestion of these complexes may be implicated in the reduction in chemotaxis observed in patients with rheumatoid arthritis. There was no correlation between the quantity of the complexes in the sera and the clinica, haematological, and biochemical measurements.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970988      PMCID: PMC1007388          DOI: 10.1136/ard.35.4.314

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

1.  The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors.

Authors:  R M Pope; M Mannik; B C Gilliland; D C Teller
Journal:  Arthritis Rheum       Date:  1975 Mar-Apr

2.  Gamma globulin complexes in rheumatoid arthritis and certain other conditions.

Authors:  H G KUNKEL; H J MULLER-EBERHARD; H H FUDENBERG; T B TOMASI
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

3.  Evidence for circulating immune complexes in thyroid disease.

Authors:  E A Calder; W J Penhale; E W Barnes; W J Irvine
Journal:  Br Med J       Date:  1974-04-06

4.  Competition for receptors for immunoglobulin on cytotoxic lymphocytes.

Authors:  I C MacLennan
Journal:  Clin Exp Immunol       Date:  1972-02       Impact factor: 4.330

5.  Inhibitory effect of rheumatoid sera on cell damage by lymphocytes.

Authors:  I G Barnett; I C MacLennan
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

6.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

7.  Characterization of the gamma-globulin complexes present in certain sera having high titers of anti-gamma-globulin activity.

Authors:  R E Schrohenloher
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

8.  A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood.

Authors:  J Baum; A G Mowat; J A Kirk
Journal:  J Lab Clin Med       Date:  1971-03

9.  Serum hyperviscosity in Sjögren's syndrome interaction between IgG and IgG rheumatoid factor.

Authors:  D Alarcón-Segovia; E Fishbein; J L Abruzzo; R Heimer
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

10.  Chemotaxis of polymorphonuclear leukocytes from patients with rheumatoid arthritis.

Authors:  A G Mowat; J Baum
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  13 in total

Review 1.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

2.  Reactivity of low molecular weight material in cellular immune complex assays.

Authors:  K M Cooper; M Moore
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

3.  Neutrophil chemotaxis in ankylosing spondylitis, Reiter's disease, and polymyalgia rheumatica.

Authors:  A G Mowat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

4.  Directed migration of circulating polymorphonuclear leucocytes in patients with rheumatoid arthritis: a defect in the plasma.

Authors:  J R Walker; D W James; M J Smith
Journal:  Ann Rheum Dis       Date:  1979-06       Impact factor: 19.103

5.  C3 receptors on granulocytes from patients with rheumatoid arthritis and Felty's syndrome.

Authors:  F C Breedveld; G J Lafeber; E De Vries; M R Daha; A Cats
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

6.  Polymorphonuclear cell function in rheumatoid arthritis and in Felty's syndrome.

Authors:  G B Howe; J N Fordham; K A Brown; H L Currey
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

7.  Interaction of circulating immune complexes with granulocyte function in patients with rheumatoid arthritis.

Authors:  B Bültmann; R Geitner; H Seibold; G Kratsch; O Haferkamp
Journal:  Klin Wochenschr       Date:  1980-07-15

8.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

9.  Neutrophil chemotaxis in rheumatoid arthritis. Effect of D-penicillamine, gold salts, and levamisole.

Authors:  A G Mowat
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

10.  D-penicillamine and immune complex deposition.

Authors:  J D Kirby; P A Dieppe; E C Huskisson; B Smith
Journal:  Ann Rheum Dis       Date:  1979-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.